Company: NOC
Filing Date: 2025-11-06
Form Type: 8-K
Source: 0001628280-25-050297
Chunk: 0

Company: NORTHROP GRUMMAN CORP /DE/
Filing Date: 2025-11-06
Form: 8-K
Item: Item 5.02
Chunk 0
---
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) (c) (e) On November 6, 2025, Northrop Grumman Corporation (the “ Company”) announced that on November 3, 2025, the Board of Directors elected John Greene, age 60, as corporate vice president and chief financial officer, effective January 7, 2026. Mr. Greene served as executive vice president, chief financial officer of Discover Financial Services from September 2019 to May 2025, when Discover Financial Services was acquired by Capital One Financial Corporation. Prior to joining Discover in 2019, Mr. Greene served as executive vice president, chief financial officer and treasurer at Bioverativ, a global biopharmaceutical company, from 2016 to March 2018. From 2014 to 2016, he was chief financial officer for Willis Group Holdings, which was preceded by more than eight years at HSBC Holdings where he served as chief financial officer for multiple business units, including retail bank and wealth management. He also held various chief financial officer roles in his 12-year tenure with General Electric from 1993 to 2005.

The Company further announced that Kenneth Crews, corporate vice president and chief financial officer, will be stepping down from his position effective January 7, 2026, but will remain an employee of the Company and serve in an advisory capacity until February 20, 2026 to ensure a smooth transition.

In connection with Mr. Greene’s election as corporate vice president and chief financial officer, the Compensation and Human Capital Committee of the Board of Directors approved a base salary for Mr. Greene of $955,000, as well as an annual incentive, a long-term incentive and other benefits commensurate with his position. The Compensation and Human Capital Committee also approved a sign-on grant comprised of Restricted Stock Rights, in accordance with the terms and conditions approved by the Compensation and Human Capital Committee, with a value of $2,000,000.